MID2 and colorectal carcinoma: Also, for the gain-of-function study, we constructed the functional pCS2-GFP-plasmid expressing the wild-type (WT) TRIM1 and the catalytically inactive mutant ΔRING TRIM1 for over-expression in CRC cells.